BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 18384225)

  • 1. Epstein-Barr virus-associated lymphoepithelioma-like gastric carcinoma.
    Herath CH; Chetty R
    Arch Pathol Lab Med; 2008 Apr; 132(4):706-9. PubMed ID: 18384225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein-Barr virus infection and microsatellite instability.
    Abe H; Maeda D; Hino R; Otake Y; Isogai M; Ushiku AS; Matsusaka K; Kunita A; Ushiku T; Uozaki H; Tateishi Y; Hishima T; Iwasaki Y; Ishikawa S; Fukayama M
    Virchows Arch; 2012 Oct; 461(4):367-77. PubMed ID: 22915242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
    Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
    Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations.
    Wu MS; Shun CT; Wu CC; Hsu TY; Lin MT; Chang MC; Wang HP; Lin JT
    Gastroenterology; 2000 Jun; 118(6):1031-8. PubMed ID: 10833477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori and EBV in gastric carcinomas: methylation status and microsatellite instability.
    Ferrasi AC; Pinheiro NA; Rabenhorst SH; Caballero OL; Rodrigues MA; de Carvalho F; Leite CV; Ferreira MV; Barros MA; Pardini MI
    World J Gastroenterol; 2010 Jan; 16(3):312-9. PubMed ID: 20082476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoepithelioma-like carcinoma of the stomach: a case report and review of the literature.
    Bittar Z; Fend F; Quintanilla-Martinez L
    Diagn Pathol; 2013 Nov; 8():184. PubMed ID: 24188515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P16 protein abnormality in Epstein-Barr virus-associated gastric carcinomas.
    Ojima H; Saito K; Yamauchi H; Yamaki E; Idetu A; Hosouchi Y; Nishida Y; Tukada K; Kato H; Kuwano H
    Anticancer Res; 2006; 26(2A):933-7. PubMed ID: 16619489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtraction of Epstein-Barr virus and microsatellite instability genotypes from the Lauren histotypes: Combined molecular and histologic subtyping with clinicopathological and prognostic significance validated in a cohort of 1,248 cases.
    Huang SC; Ng KF; Yeh TS; Cheng CT; Lin JS; Liu YJ; Chuang HC; Chen TC
    Int J Cancer; 2019 Dec; 145(12):3218-3230. PubMed ID: 30771224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsatellite instability, Epstein-Barr virus, mutation of type II transforming growth factor beta receptor and BAX in gastric carcinomas in Hong Kong Chinese.
    Leung SY; Yuen ST; Chung LP; Chu KM; Wong MP; Branicki FJ; Ho JC
    Br J Cancer; 1999 Feb; 79(3-4):582-8. PubMed ID: 10027334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer.
    Park JH; Kim EK; Kim YH; Kim JH; Bae YS; Lee YC; Cheong JH; Noh SH; Kim H
    Gastric Cancer; 2016 Oct; 19(4):1041-1051. PubMed ID: 26573601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus infection serves as an independent predictor of survival in patients with lymphoepithelioma-like gastric carcinoma.
    Min BH; Tae CH; Ahn SM; Kang SY; Woo SY; Kim S; Kim KM
    Gastric Cancer; 2016 Jul; 19(3):852-9. PubMed ID: 26265391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Participation of p53 and bcl-2 Proteins in Gastric Carcinomas Associated with Helicobacterpylori and/or Epstein-Barr Virus (EBV).
    Szkaradkiewicz A; Karpiński TM; Majewski J; Malinowska K; Goślińska-Kuźniarek O; Linke K
    Pol J Microbiol; 2015; 64(3):211-6. PubMed ID: 26638529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-associated gastric adenocarcinoma in Taiwan.
    Harn HJ; Chang JY; Wang MW; Ho LI; Lee HS; Chiang JH; Lee WH
    Hum Pathol; 1995 Mar; 26(3):267-71. PubMed ID: 7890276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interrelationship between Epstein-Barr virus infection in gastric carcinomas and the expression of apoptosis-associated proteins.
    Ishii H; Gobé G; Kawakubo Y; Sato Y; Ebihara Y
    Histopathology; 2001 Feb; 38(2):111-9. PubMed ID: 11207824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer.
    Pereira MA; Ramos MFKP; Faraj SF; Dias AR; Yagi OK; Zilberstein B; Cecconello I; Alves VAF; de Mello ES; Ribeiro U
    J Surg Oncol; 2018 Apr; 117(5):829-839. PubMed ID: 29534305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus-associated lymphoepithelioma-like gastric carcinoma presenting as a submucosal mass: CT findings with pathologic correlation.
    Kim SW; Shin HC; Kim IY; Kim CJ; Lee JH; Lee CK; Jeong DJ
    Korean J Radiol; 2010; 11(6):697-700. PubMed ID: 21076598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epstein-Barr virus-associated gastric adenocarcinoma].
    Danilova NV; Malkov PG; Oleynikova NA; Mikhailov IA
    Arkh Patol; 2019; 81(3):74-83. PubMed ID: 31317934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
    Zheng X; Wang J; Wei L; Peng Q; Gao Y; Fu Y; Lu Y; Qin Z; Zhang X; Lu J; Ou C; Li Z; Zhang X; Liu P; Xiong W; Li G; Yan Q; Ma J
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoepithelioma-like gastric carcinoma: an unusual consequence of Epstein-Barr virus infection in an HIV-infected woman.
    Paniz-Mondolfi P; Pang Y; Cohen S; Balderacchi J; Tsveniashvili L; Polsky B; Sordillo EM
    Int J STD AIDS; 2013 Jan; 24(1):59-62. PubMed ID: 23440571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer.
    Zhao J; Jin H; Cheung KF; Tong JH; Zhang S; Go MY; Tian L; Kang W; Leung PP; Zeng Z; Li X; To KF; Sung JJ; Yu J
    Cancer; 2012 Feb; 118(4):924-36. PubMed ID: 21717425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.